title: Severe nervous system complications after botulinum type A therapy: three case reports with reviews of FDA-reported nervous system adverse effects.
authors.affiliation: Neurology Department, Virginia Commonwealth University, MCV Campus ACC5, 417 N 11th St., Richmond, VA 23298-0599, USA. annahri@gmail.com
authors.forename: Anna H
authors.initials: AH
authors.lastname: Hristova
authors.forename: Lenore N
authors.initials: LN
authors.lastname: Joseph
authors.forename: Swati A
authors.initials: SA
authors.lastname: Sathe
authors.forename: James B
authors.initials: JB
authors.lastname: Wade
mesh_terms: D001764:Blepharospasm / Q000188:drug therapy; D019274:Botulinum Toxins, Type A / Q000009:adverse effects*; D015897:Comorbidity; D004421:Dystonia / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009422:Nervous System Diseases / Q000139:chemically induced*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D019274:Botulinum Toxins, Type A